Bird&Be raises $13M for its ‘Both Partners’ strategy
Bird&Be Secures $13 Million to Accelerate Fertility Wellness Innovation
The landscape of fertility wellness is evolving, and brands that prioritize a holistic, partnership-focused approach are finding massive traction. At the forefront of this movement is Bird&Be, a fertility brand that is successfully blending at-home testing and targeted supplements to empower individuals on their wellness journey.
To fuel its ambitious growth and innovation, Bird&Be recently announced a successful fundraising round, securing 13 million dollars. This significant capital infusion is set to power crucial initiatives aimed at advancing product development, deepening clinical research, and expanding the brand’s reach across retail channels and healthcare providers.
This investment underscores the market’s growing demand for accessible, science-backed fertility solutions. By backing Bird&Be, investors are supporting a model that recognizes the complexity of fertility and emphasizes the importance of the “both partners” approach in achieving successful outcomes.
The funding was led by several influential partners, including BDC Thrive, which operates as part of BDC Capital’s expansive $500 million initiative dedicated to backing women-led businesses in Canada, alongside BFG Partners. This backing signals strong confidence in Bird&Be‘s ability to scale its innovative offerings and make a tangible difference in the wellness industry.
With this capital, Bird&Be is poised to take its unique methodology and bring it to a broader audience, ensuring that cutting-edge fertility support remains accessible and effective for those navigating the complexities of conception and family building.